BRCA1 and BRCA2 are tumor suppressor genes, meaning when they function normally their job is to keep tumors from forming. Some people however, have an altered or mutated copy of the gene and certain mutations are associated with an increased risk for several cancer types, including breast, ovarian, prostate, pancreatic, melanoma, and in some families, colorectal.
One of the biggest challenges in treating ovarian cancer is the fact that most women are not diagnosed until the cancer has already advanced and five-year survival is around 30%. By contrast, early-stage disease is highly treatable, with a survival rate of 90%.
Even if you already have cancer, you can’t let down your guard when it comes to prevention. In fact, cancer patients have even more reason to be on guard, because they usually have a higher risk for infection or developing other types of cancer.
In an effort to stop the tobacco industry from targeting younger generations, the U.S. government took aim at youth vaping early this year, banning some e-cigarette flavors — like mint and fruit flavors.
Researchers at Roswell Park Comprehensive Cancer Center have been actively engaged in the effort to develop treatments or other control strategies that can help communities worldwide to address the impacts of the COVID-19 pandemic.